Periop med Flashcards

1
Q

What are the 6 components of the Revised cardiac risk index (Lee Index)

A

High risk surgery (intraperitoneal, intrathoracic, suprainguinal vascular)
History of IHD
History of CHF
History of cerebrovascular disease (CVA or TIA)
IDDM
Pre-operative serum creat >172

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Minor surgical stress (cardiac risk

A
Endoscopic procedures
Superficial procedure
Cataract
Breast
Ambulatory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Moderate surgical stress (cardiac risk 1-5%) includes

A
Intraperitoneal and intrathoracic surgery
Carotid endarterectomy
Head and neck surgery
Orthopedic
Prostate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Major surgical stress (cardiac risk >5%) includes

A

Aortic and other major vascular surgery

Peripheral vascular surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Indications for per-operative EKG

A

Look at number of clinical risk factors and risk of surgery;

  • 1 RF + Vascular surgery OR intermediate risk
  • 0 RF + vascular surgery
  • Known CHD, PAD, CVA + intermediate risk procedure
  • pre-op and post-op EKGs not indicated in asymptomatic ppl undergoing low risk surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Indications for non invasive stress testing (treadmill, Dobu stress echo, Dip Mibi)

A

-indicated in pts 3+ clinical risk factors AND

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risk stratification for period medicine

A

Emergency: life or limb threatened 1-6 weeks to allow for an evaluation
Elective procedure: delayed for up to 1 year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical Risk factors

A

CAD

Heart Failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CAD and perioperative mortality

A
  • major adverse cardiac events after non cardiac surgery often associated with prior CAD
  • postoperative MI rate decreased substantially as length of time from MI to operation increased; 60 days (magic number) should elapse after MI before non cardiac surgery in absence of a coronary intervention
  • recent MI defined as having occurred within 6 months of non cardiac surgery was found to be independent risk factor for perioperative stroke which was associated with 8fold increase in perioperative mortality rate
  • age increases risk of CAD, and thus cardiac risk period; >55
  • age >65 undergoing noncardiac surgery had increase risk of stroke
  • history of CVA predicts perioperative major adverse cardiac event
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Heart Failure

A
  • have higher risk of post-operative death than CAD (although emphasis often placed on CAD)
  • Survival after surgery for pts with EF 30%
  • it is inappropriate to assess ventricular function in pts without signs or symptoms of CV disease in preop setting (although some data to suggest that pts with a/symptomatic decr EF have increased risk of 30 day cardiovascular event rate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Indications for pre-operative ECHO

A

-If clinically suspect (hear murmur) moderate or greater degrees of valvular stenosis or regurgitation if
=> no ECHO within 1 year
=> significant change in clinical status or physical exam since last evaluation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Concern re AS

A

Does increase perioperative (30 day) mortality which increases as degree of AS increases
Consider AVR vs TAVR if eligible
If not, can proceed with surgery but ensure appropriate hemodynamic monitoring (ICU) post op

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Concern re MS

A

Ensure appropriate hemodynamic monitoring post op

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Arrhythmias (VT periop)

A

Ventricular premature beats and NSVT are risk factors for development of intraoperative and post op arrhythmias, not associated with increases of nonfatal MI or cardiac death in perioperative period
HOWEVER; these pts do require referral to cardiologists for further evaluation, including assessment of Ventricular function and screening for CAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Conduction disease

A
  • High grade conduction blocks can increase risk of complete AVB which if unanticipated may increase surgical risk and necessity temporary or permanent transvenous pacing
  • pts with AV delays ex LBBB or RBBB but no history of advanced heart block or symptoms, rarely progress to complete AVB perioperatively
  • presence of pre-existing conduction disorders like sinus node dysfunction and AVB requires caution of perioperative beta blockers being considered
  • periop BBB and bifasciular block do not contraindicate use of bb
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Perioperative arrhythmia differential

A

Ongoing Ischemia
Underlying cardiopulmonary disease
Drug toxicity
Metabolic derangements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pulmonary vascular disease during perioperative period (pulmonary hypertension)

A
  • Continue pulmonary vascular targeted therapy (PDE5 inhibitors…) unless contraindicated or not tolerated in pts with pulmonary htn undergoing non cardiac surgery
  • unless the risks of delay outweight benefits of preoperative evaluation by pulmonary htn specialists before noncardiac surgery, can be beneficial to have specialists in PH come see, especially n pts with features of increased perioperative risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MACE (what does this mean)

A
MI
Pulmonary edema
Vfib
Primary cardiac arrest
Complete heart block
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Low risk based on RCRI score

A

0-1 RF LOW risk of MACE

>2 (inclusive) elevated risk MACE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

minimum requirement of glucose perop to prevent catabolism

A

5g of glucose/hour = 100 cc D5W

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When to hold Sulfonylurea pre surgery

A

**be aware of long half lives
HOLD AM for surgery for all
Hold 24-48 hours pre-op for long acting agents (glyburide, glimepiride, glipizide)
Note that half life increases with liver/kidney dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How to manage pts with insulin pump peri-op

A

Continue basal dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How to manage pts on long acting peakless insulin peri-op (ex lantus)

A

Day before surgery
-decrease dose by 30%
Day of surgery
-give 70% of AM dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How to manage pts on Intermediate acting insulin periop

A

Day before
-reduce night dose by 30%
Day surgery
-give 50-60% AM dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How to manage pts on fixed combination insulin doses

A

Day before
-no change
Day of usrgery
-50-60% AM dose of NPH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Optimal glycemic control in hospitalized patients peri op

A

8-11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How to manage insulin when pt on MDI regimen (RRRN)

A

Calculate Total daily dose insulin (TDD)
divide by 4
Divide that dose into BID NPH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How to manage insulin when pt on mixed insulins

A

Calculate NPH dose given AM and PM

Give 1/2 AM NPH and 1/2 PM NPH dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Unfractionated heparin dosing

A

consult thrombosis if weight >120 kg

Prophylaxis 5000 increases to Q8 if obese >120 kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

LMWH dosing therapeutic

A

Therapeutic; 1.5 mg/kg SC DIE OR 1 mg/kg SC BID (latter preferred in obesity and ACS)

31
Q

LMWH dosing prophylactic

A

40 mg DIE except in post op hip/knee surgeries where it’s 30 mg SC BID
Renal failure Cr Cl 15-30 use 30 mg SC DIE

32
Q

Special consideration in dosing adjustment for LMWH should be made for pts with weight above…

A

120 kg

33
Q

Xarelto

A

Rivaroxaban

Xa inhibitor

34
Q

Pradax

A

Dabigatran

Direct thrombin inhibitor

35
Q

Dosing dabigatran

A

150 mg PO BID
110 mg pO BID if age >75 OR pts with increased risk of bleeding
At JGH contraindicated in pts > 75 with CrCl

36
Q

Monitoring Dabigatran

A

PTT if abnormal indicates drug present BUT normal PTT does not mean there is no effect of dabigatrarin
Thrombin Time; normal TT indicates no remaining anticoagulant effect from dabigatran BUT abnormal TT does not imply that hemostasis is impaired

37
Q

Anticoagulation option in pts with HITs

A

Argatroban
Direct thrombin inhibitor
No dose adjustment needed in renal failure

38
Q

If INR > 10

A

Hold warfarin until INR therapeutic
Vit K 2.5 mg PO x1
Restart warfarin lower dose

39
Q

INR 4.5-10

A

hold warfarin until therapeutic

restart at lower dose

40
Q

INR

A

decrease warfarin by 10-20%

41
Q

INR > 2 and urged procedure needed

A

HOLD warfarin
Octaplex unless contraindication
Vit K 10 mg IV over 30 min
INR corrects within 1 hour

If not octaplex candidate

  • vita K 5-10 mg IV over 30 min
  • FFP
  • INR corrects within 8 hour
42
Q

Contraindications to octaplex

A

history of HIT
allergy
high risk thrombosis (recent MI, PE, DVT, CVA)

43
Q

Vit K

A

IV vitamin K associated with anaphylaxis
should be reserved for urgent situations to reverse anticoagulation
otherwise PO vit K should be used
Response to SC vit K unpredictable and sometimes delayed

44
Q

Bleeding on Dabigatrarn and Rivaroxaban

A

Supportive care with PRBC and FFP while drug wears off

Dialysis suggested for dabigatran but efficacy unproven

45
Q

Hasbled > 3

A

closer monitoring and follow-up is warranted

46
Q

Cardioversion of fib and anticoagulation

A

warfarin recommended for 3 weeks before and 4 weeks after cardioversion at least; duration will be determined by treating cardiologist

47
Q

Duration anticoagulation unprovoked VTE

A

Warfarin x 3 months OR rivaroxaban

48
Q

2nd unprovoked VTE duration anicoagulation

A

warfarin should be continued possibly indefinitely Or rivaroxaban

49
Q

Provoked VTE duration anticoagulation

A

3 months

50
Q

Thrombophilia work up in pt with VTE

A

Done in unprovoked and pregnancy associated DVTs as it will affect

  • secondary prophylaxis decisions in high risk situation
  • primary prophylaxis in first degree relatives
  • can affect duration of therapy
51
Q

Thrombophilia w/u pts

A

Antithrombin, Prot C and S, factor V Leiden, Prothrombin mutation, lupus anticoagulation and anticardiolipin antibodies, homocystein factor VIII levels

52
Q

Thrombophilia w/u in pts >55

A

Factor V Leiden, Prothrombin mutation, lupus anticoagulant, anticardiolipin antibodies, homocystein, factor VIII

53
Q

Pregnancy and anticoagulation

A
  • Dx with VTE=> LMWH for pregnancy + 6 weeks post part
  • warfarin contraindication during 1/3 pregnancy
  • primary prophylaxis for thrombophilic women during six weeks post part (LMWH)
  • secondary prophylaxis during pregnancy indicated for VTE associated with
  • VTE ass estrogen use/thrombophilia, pregnancy/obesity, unprovoked VTE,
54
Q

Anticoagulation post partum

A

LMWH or warfarin
Neither are excreted in breast milk
both safe for newborn

55
Q

CA-associated VTE

A

first 6 months LMWH (dalteparin or ex) then can switch for warfarin if pt prefers
anticoagulation continued indefinitely

56
Q

Thrombosis associated with lupus anticoagulant

A

lifelong warfarin

57
Q

Lupus anticoagulant and recurrent fetal loss

A

treated with prophylactic LMWH + ASA for all subsequent pregnancy

58
Q

Heparin prophylaxis and GFR

A

contraindicated if GFR

59
Q

Bioprosthetic valves and ASA

A

MV; ASA indefinitely, warfarin for 3 months

AV; ASA x 3 months

60
Q

High risk patients who require bridging therapy

A

CHADS 5-6
VTE within 3 months if indication is fib
Severe thrombophilia
CVA or TIA in past 6 months if indication VTE

61
Q

moderate risk for thrombotic events in pts CHADS 3-4

A

increasing risk if have had

  • VTE in past 3-12 months
  • recurrent VTE
  • active CA treated within 6 months or palliative
62
Q

high risk bleeding surgery

A
Major orthopaedic surgery
GU surgery
neurosurgery
Vascular surgery
Endoscopy with possibility of biopsy
TAH
63
Q

When to use ASA and Warfarin

A

-secondary prophylaxis of IHD in pts with CAD

64
Q

Indication for Coumadin in CAD/HF

A
  • large anterior MI
  • significant heart failure + Afib or thrombus or systemic arterial event
  • intracardiac thrombus on echo
  • history thromboembolic event
  • use warfarin X 3 months + Asa life
65
Q

Chance of restenosis with BMS

A

20-30%

66
Q

Duration of ASA with BMS or DES

A

Indefinite

67
Q

Duration of P2Y inhibitor (clopidogrel) with BMS vs DES stent

A

BMS at least 1` month but ideally up to 12 months

DES at least 12 months

68
Q

Guidelines re bleeding and stents

A

Delay surgery at least 6 weeks after BMS
Delay surgery 6 weeks after DES (ideally 1 year)
For pts requiring surgery during this timeframe suggest continuing dual antiplatelet therapy perioperatively

69
Q

Asessment of LV function pre-op indications

A
  • dyspnea unknown origin
  • HF and worsening dyspnea
  • stable pts with LV dysfunction with no ECHO in a year
  • routine preop eval of LV function not indicated
70
Q

low EF and prediction of cardiac events

A

Highest risk patients with EF

71
Q

Exercise stress testing indication

A

Indicated in pts with elevated risk and unknown function capacity
If good functional capacity and asymptomatic, no need for exercise stress testing
In pts with METS

72
Q

Pharmacological stress testing (dobu) indications periop

A

indicated in pts

73
Q

Indications for preop coronary angiograph

A

NONE!
No indication for routine
Revascularization is not specifically indicated before noncardiac surgery to reduce periop cardiac events

74
Q

Timing of elective noncardiac surgery after PCI

A

14 days after balloon angioplasty
30 days after BMS
365 days after DES